Dermatitis and alopecia

Yevgeniy Balagula, Mario E. Lacouture

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

A fundamental shift in chemotherapeutic approach has occurred over the last several decades. A new class of so-called targeted agents, designed to target aberrant molecular pathways responsible for promoting carcinogenesis, was added to the arsenal of cytotoxic drugs that target rapidly proliferating tumor cells. These advances improved patient care and decreased morbidity and mortality. While systemic adverse events such as bone marrow suppression and gastrointestinal toxicities have diminished with the use of targeted agents, the spectrum of dermatologic toxicities have expanded. Mechanisms underlying the development of such a variety of cutaneous adverse events remain to be elucidated, but a significant amount of data shedding light on potential pathophysiology has accumulated. This chapter will review these data.

Original languageEnglish (US)
Title of host publicationPathobiology of Cancer Regimen-Related Toxicities
PublisherSpringer New York
Pages147-166
Number of pages20
ISBN (Print)9781461454380, 9781461454373
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

Dermatologic Agents
Alopecia
Dermatitis
Patient Care
Carcinogenesis
Bone Marrow
Morbidity
Skin
Mortality
Pharmaceutical Preparations
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Balagula, Y., & Lacouture, M. E. (2013). Dermatitis and alopecia. In Pathobiology of Cancer Regimen-Related Toxicities (pp. 147-166). Springer New York. https://doi.org/10.1007/978-1-4614-5438-0

Dermatitis and alopecia. / Balagula, Yevgeniy; Lacouture, Mario E.

Pathobiology of Cancer Regimen-Related Toxicities. Springer New York, 2013. p. 147-166.

Research output: Chapter in Book/Report/Conference proceedingChapter

Balagula, Y & Lacouture, ME 2013, Dermatitis and alopecia. in Pathobiology of Cancer Regimen-Related Toxicities. Springer New York, pp. 147-166. https://doi.org/10.1007/978-1-4614-5438-0
Balagula Y, Lacouture ME. Dermatitis and alopecia. In Pathobiology of Cancer Regimen-Related Toxicities. Springer New York. 2013. p. 147-166 https://doi.org/10.1007/978-1-4614-5438-0
Balagula, Yevgeniy ; Lacouture, Mario E. / Dermatitis and alopecia. Pathobiology of Cancer Regimen-Related Toxicities. Springer New York, 2013. pp. 147-166
@inbook{671cdc10e5994c699b0a00f7a5a42356,
title = "Dermatitis and alopecia",
abstract = "A fundamental shift in chemotherapeutic approach has occurred over the last several decades. A new class of so-called targeted agents, designed to target aberrant molecular pathways responsible for promoting carcinogenesis, was added to the arsenal of cytotoxic drugs that target rapidly proliferating tumor cells. These advances improved patient care and decreased morbidity and mortality. While systemic adverse events such as bone marrow suppression and gastrointestinal toxicities have diminished with the use of targeted agents, the spectrum of dermatologic toxicities have expanded. Mechanisms underlying the development of such a variety of cutaneous adverse events remain to be elucidated, but a significant amount of data shedding light on potential pathophysiology has accumulated. This chapter will review these data.",
author = "Yevgeniy Balagula and Lacouture, {Mario E.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1007/978-1-4614-5438-0",
language = "English (US)",
isbn = "9781461454380",
pages = "147--166",
booktitle = "Pathobiology of Cancer Regimen-Related Toxicities",
publisher = "Springer New York",

}

TY - CHAP

T1 - Dermatitis and alopecia

AU - Balagula, Yevgeniy

AU - Lacouture, Mario E.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - A fundamental shift in chemotherapeutic approach has occurred over the last several decades. A new class of so-called targeted agents, designed to target aberrant molecular pathways responsible for promoting carcinogenesis, was added to the arsenal of cytotoxic drugs that target rapidly proliferating tumor cells. These advances improved patient care and decreased morbidity and mortality. While systemic adverse events such as bone marrow suppression and gastrointestinal toxicities have diminished with the use of targeted agents, the spectrum of dermatologic toxicities have expanded. Mechanisms underlying the development of such a variety of cutaneous adverse events remain to be elucidated, but a significant amount of data shedding light on potential pathophysiology has accumulated. This chapter will review these data.

AB - A fundamental shift in chemotherapeutic approach has occurred over the last several decades. A new class of so-called targeted agents, designed to target aberrant molecular pathways responsible for promoting carcinogenesis, was added to the arsenal of cytotoxic drugs that target rapidly proliferating tumor cells. These advances improved patient care and decreased morbidity and mortality. While systemic adverse events such as bone marrow suppression and gastrointestinal toxicities have diminished with the use of targeted agents, the spectrum of dermatologic toxicities have expanded. Mechanisms underlying the development of such a variety of cutaneous adverse events remain to be elucidated, but a significant amount of data shedding light on potential pathophysiology has accumulated. This chapter will review these data.

UR - http://www.scopus.com/inward/record.url?scp=84956489421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956489421&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-5438-0

DO - 10.1007/978-1-4614-5438-0

M3 - Chapter

AN - SCOPUS:84956489421

SN - 9781461454380

SN - 9781461454373

SP - 147

EP - 166

BT - Pathobiology of Cancer Regimen-Related Toxicities

PB - Springer New York

ER -